Advanced and Selected Solid Tumors Completed Phase 1 Trials for Trametinib (DB08911)

IndicationStatusPhase
DBCOND0047995 (Advanced and Selected Solid Tumors)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01155453A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor PatientsTreatment